Cytek Biosciences Inc (CTKB)

Cost of Revenue

$19.80M

Quarterly · Period ending: · USD

CTKB logo

CTKB Cost of Revenue

Latest reported$19.80M
CTKB Quarterly Cost of Revenue ($9.61M → $19.80M)
High-resolution chart · PNG

CTKB cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytek Biosciences Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
19,800,000
22,881,000
29,256,000
24,742,000
21,735,000
21,300,000
23,824,000
22,495,000
21,181,000
21,847,000
25,185,000
20,822,000
21,531,000
16,050,000
18,962,000
13,615,000
15,598,000
14,887,000
15,258,000
13,099,000
10,663,000
9,786,000
11,170,000
9,480,000
10,866,000
9,613,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.